These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14912473)

  • 1. [Hyperhemolysis and erythroblastosis in an adult with remarkable autoagglutination of the erythrocytes].
    CARNESECCHI V; RICCI GC
    Rass Fisiopatol Clin Ter; 1951 Jan; 23(1):119-28. PubMed ID: 14912473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Frequency and significance of erythroblastosis in blood diseases caused by benzene].
    CREPET M; PRATO V
    Folia Med (Napoli); 1955 Sep; 38(9):934-56. PubMed ID: 13277568
    [No Abstract]   [Full Text] [Related]  

  • 3. [The chemical element content of the erythrocytes in polycythemia vera].
    Vydyborets SV; Tishchenko LM
    Vrach Delo; 1989 Oct; (10):80-1. PubMed ID: 2617995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasma erythropoietic-stimulating factor in man; observations on patients with polycythemia vera and secondary polycythemia.
    BETHELL FH; LINMAN JW
    J Lab Clin Med; 1957 Jan; 49(1):113-27. PubMed ID: 13385582
    [No Abstract]   [Full Text] [Related]  

  • 5. The life span of the red blood cell in chronic leukemia and polycythemia.
    BERLIN NI; LAWRENCE JH; LEE HC
    Science; 1951 Oct; 114(2963):385-7. PubMed ID: 14883866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemoglobin content of the blood in anemia, polycythemia vera & polyglobulisms].
    RICHTER K
    Klin Wochenschr; 1958 Oct; 36(19):911-4. PubMed ID: 13599441
    [No Abstract]   [Full Text] [Related]  

  • 7. The circulating red blood cell volume. I. Its relationship to the peripheral blood cell counts in normal subjects and persons with polycythemia.
    LICHTMAN HC; RABINER SF
    AMA Arch Intern Med; 1957 Jan; 99(1):8-13. PubMed ID: 13393828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aldolase, lactic dehydrogenase, and glutamic oxalacetic transaminase activity in plasma and erythrocytes in polyglobulia and polycythemia].
    VETTER K
    Z Gesamte Inn Med; 1960 Apr; 15():367-70. PubMed ID: 13842014
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxygen and the control of red cell production in primary and secondary polycythemia; effects on the iron turnover patterns with Fe59 as tracer.
    LAWRENCE JH; ELMLINGER PJ; FULTON G
    Cardiologia (Basel); 1952; 21(4):337-46. PubMed ID: 13019789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of a substance furthering the multiplication of erythrocytes and reticulocytes in polycythemia vera in experiments on animals].
    APPELS A; KELLER HM
    Folia Haematol (Frankf); 1957 Aug; 1(4):309-19. PubMed ID: 13473975
    [No Abstract]   [Full Text] [Related]  

  • 11. The zinc content of plasma and erythrocytes of patients with pernicious anemia, sickle cell anemia, polycythemia vera, leukemia, and neoplastic disease.
    TALBOT TR; ROSS JF
    Lab Invest; 1960; 9():174-84. PubMed ID: 13836725
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of sulfhydryl groups on erythrocytes in polycythemia vera.
    Hougland MW; Luethke JM
    Histochemistry; 1982; 76(1):57-60. PubMed ID: 7174367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytometric characteristics of erythrocytes in polycythemia vera].
    Kotsiubinskiĭ NN; Dygin VP; Koval' IuV
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):33-6. PubMed ID: 7045861
    [No Abstract]   [Full Text] [Related]  

  • 14. Elongation index of erythrocytes, study of activity of chosen erythrocyte enzymes, and the levels of glutathione, malonyldialdehyde in polycythemia vera (PV).
    Dąbrowski Z; Dybowicz AJ; Marchewka A; Teległów A; Skotnicki A; Zduńczyk A; Aleksander P; Filar-Mierzwa K
    Clin Hemorheol Microcirc; 2011; 47(3):169-76. PubMed ID: 21498896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects of erythrocyte kinetics in hematologic disorders].
    Honetz N
    Wien Z Inn Med; 1972; 53(2):58-85. PubMed ID: 4504755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythrocyte life span in polycythemia vera; studies with radiochromium].
    RICHTER K; BRUSCHKE G
    Klin Wochenschr; 1959 Feb; 37(3):150-8. PubMed ID: 13642724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic myeloproliferative diseases. Erythrocyte apheresis in polycythemia vera].
    Kaboth U; Rumpf KW; Hiddemann W; Kaboth W
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1483. PubMed ID: 8983902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
    Gudim VI; Sarycheva TG; Kotel'nikov VM; Melikian AL; Ivanova VS
    Ter Arkh; 1987; 59(6):48-51. PubMed ID: 3629498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte cholesterol content in polycythemia vera: relation to ischemic heart disease].
    Torkhovskaia TI; Khalilov EM; Gorokhovskaia GN; Fortinskaia ES; Soboleva VV; Kochetova MM; Nikitina NA; Martynov AI
    Kardiologiia; 2003; 43(9):49-51. PubMed ID: 14593369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the erythro-myeloid transformations of Vaquez erythremia].
    Marchal G; Mallet L; Beau H; Duhamel G
    Bull Mem Soc Med Hop Paris; 1954; 70(21-23):822-6. PubMed ID: 13209341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.